Nihat Akbulut

Dr. Nihat Akbulut

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2018 in Oral Radiology
Verified
Journal Article
Closed access
PDF file
KDKemal Özgür Demiralp
Kemal Özgür Demiralp
EKEmine Şebnem Kurşun-Çakmak
Emine Şebnem Kurşun-Çakmak
SBSeval Bayrak
Seval Bayrak
NANihat Akbulut
Nihat Akbulut
Cemal ATAKANCemal ATAKAN
Cemal ATAKAN
KOKaan Orhan
Kaan Orhan

1 April 2013 in European Journal of Dentistry
Verified
Journal Article
Open access
PDF file
NANihat Akbulut
Nihat Akbulut
EKE. Sebnem Kursun
E. Sebnem Kursun
MTM. Kemal Tumer
M. Kemal Tumer
KKKivanc Kamburoglu
Kivanc Kamburoglu
UGUgur Gulsen
Ugur Gulsen
Objective: To evaluate the safety and efficacy of an 810-nm diode laser for treatment of benign oral soft tissue lesions. Materials and Methods: Treatment with the 810-nm diode laser was applied to a group of eighteen patients with pathological frenulum and epulis fissuratum; five patients with oral lichen planus, oral leukoplakia, and mucous membrane pemphigoid; and four patients with pyogenic granuloma. Results: Although the conventional surgery wound heals in a fairly short time, in the present study, the simple oral soft tissue lesions healed within two weeks, the white and vesiculobullous lesions healed completely within six weeks, and the pyogenic granuloma lesions healed within four weeks. Any complication was treated by using the 810-nm diode laser. Conclusions: Patient acceptance and satisfaction, without compromising health and function, have been found to be of a high degree in this present study. Thus, we can say that the use of the 810-nm diode laser may indeed be the best choice in oral soft tissue surgery.

1 January 2014 in Medicina Oral Patología Oral y Cirugia Bucal
Verified
Journal Article
Open access
NANihat Akbulut
Nihat Akbulut
EUE. Ustuner
E. Ustuner
Cemal ATAKANCemal ATAKAN
Cemal ATAKAN
GCG. Colok
G. Colok
Objectives: To compare the three non-steroidal anti-inflammatory agents (NSAIDs) diclofenac potassium, etodolac and naproxen sodium in relation to pain, swelling and trismus following impacted third molar surgery. Study Design: The study was a randomized and a double-blinded study which included 42 healthy young individuals with impacted third molars and bone retention. Patients were randomly assigned to 3 groups (n: 14) to which diclofenac potassium, naproxen sodium and etodolac were administered orally an hour before the operation. Impacted third molars were surgically extracted with local anaesthesia. Visual analog scales (VAS) were used to assess the pain in the 6th, 12th hours and on the 1st, 2nd, 3rd, 5th, and 7th days postoperatively. Swelling was evaluated using ultrasound (US) and mouth opening (trismus) was measured with a composing stick pre and post operatively on the 2nd and 7th days respectively. Results: Regarding pain alleviation, diclofenac potassium was better than naproxen sodium and naproxen sodium was better than etodolac but these differences were not statistically significant. US measurements showed that the swelling on postoperative 2nd day was significantly lowest with diclofenac potassium as compared to others (p= 0.027) while naproxen sodium and etodolac acted similarly (p=0.747). No difference was noted regarding trismus in any of the groups. Conclusions: NSAIDs (diclofenac, naproxen and etodolac) are somehow similarly effective for controlling pain and trismus following extraction of mandibular third molars but diclofenac potassium surpasses others in reduction of swelling.

3 July 2019 in International journal of legal medicine
Verified
Journal Article
Closed access
PDF file
NANihat Akbulut
Nihat Akbulut
SÇSelçuk Çetin
Selçuk Çetin
BBBurak Bilecenoğlu
Burak Bilecenoğlu
AAAhmet Altan
Ahmet Altan
SASibel Akbulut
Sibel Akbulut
KOKaan Orhan
Kaan Orhan

6 July 2011 in Journal of Medical Case Reports
Verified
Journal Article
Open access
PDF file
NANihat Akbulut
Nihat Akbulut
BOBengi Oztas
Bengi Oztas
SKSebnem Kursun
Sebnem Kursun
SESehrazat Evirgen
Sehrazat Evirgen
In malign neoplasms, oral cancer is one of the important causes of mortality and morbidity. Squamous cell carcinoma is the most common form of oral cancers in adults and is related to risk factors such as smoking and alcohol consumption.

5 December 2018 in Pain Research and Management
Verified
Journal Article
Open access
PDF file
NANihat Akbulut
Nihat Akbulut
AAAhmet Altan
Ahmet Altan
SASibel Akbulut
Sibel Akbulut
Cemal ATAKANCemal ATAKAN
Cemal ATAKAN
Objective. This study aimed at finding out whether the 3 mm thickness of stabilization splints has positive or negative effects on all temporomandibular disorder (TMD) symptoms. Materials and Methods. The statistical calculation included 25 (22 females; 3 males) TMD patients who received 3 mm thickness stabilization splint therapy. They were evaluated according to follow-up treatment period, TMD pain, muscle pain, mouth opening, diet score, and splint usage time per day. Results. There was important treatment success that 22 (88%) of patients were totally healed. There was not any remarkable effect or advancement of splints on total healings of TMDs in first 3 months’ period (11/25 patients, 44%). The mouth opening mean reached 38, 67 mm at 6 months and 41 mm at 12 months with remarkable success. Except one (4%) patient, other 24 (96%) patients had a normal diet score of 3 at the end of splint therapy. There was no correlation between splint usage duration a day and total healing of TMDs. Conclusion. We conclude that 3 mm splint therapy should maintain at least 6 months to achieve remarkable results. Splint should be used at least 12 h a day consistent with our results. Finally, diet score should be incorporated with TMD pain and amount of mouth opening; hence, we advise to use in one term as “total healing.”